Adjuvant Chemotherapy Trial of TS-1 for Gastric Cancer (ACTS-GC)
Interventional
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment
Overall survival
every course for first three courses, then every other course
No
Mitsuru Sasako, MD
Principal Investigator
Department of Upper Gastrointestinal Surgery, Hyogo College of Medicine
Japan: Ministry of Health, Labor and Welfare
91023038
NCT00152217
September 2001
December 2010
Name | Location |
---|